nirmatrelvir + ritonavir

all catalysts(0)

nothing on the calendar yet

News(2)

• Earnings roundup: Gilead’s ‘uncertain’ future, Pfizer’s crossroads and Merck’s PCSK9 launch
  Some analysts see warning signs in crucial drug launches from Gilead and Merck, while an important trial readout could change Pfizer’s growth trajectory.
  biopharma_dive · 9d ago
• Opinion: It’s time to treat pandemics as threats to national security
  “Pandemics should be viewed and combated as threats to national security,” write David Blumenthal and James A. Morone.
  stat · 25d ago